| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-β-hydroxyphenethylamine; β-Hydroxy-3,4-methylenedioxyphenethylamine; β-Hydroxy-MDPEA; Methylenedioxyethanolamine; MDE |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C9H11NO3 |
| Molar mass | 181.191 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BOHH, also known as 3,4-methylenedioxy-β-hydroxyphenethylamine or as β-hydroxy-MDPEA, is a chemical compound of the phenethylamine, MDxx, and BOx families related to 3,4-methylenedioxyphenethylamine (MDPEA).[1][2] It is the β-hydroxy derivative of MDPEA and the β-O-desmethyl analogue of BOH (β-methoxy-MDPEA).[1][2] The drug is also the 3,4-methylenedioxy analogue of the neurotransmitter norepinephrine.[1]
According to Alexander Shulgin in his book Phenethylamines I Have Known and Loved (PiHKAL) and other publications, BOHH is inactive at doses of up to 100 mg orally.[1][2] On the other hand, Michael Valentine Smith claimed in his book Psychedelic Chemistry that BOHH "is said to be a very fine trip", with no other information provided.[3]
BOHH was first described in the scientific literature by at least 1981.[3] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]
The analogous derivative of BOH is 3,4-methylenedioxyphenyl-β-ethanolamine (BOHH). In the early literature it is occasionally referred to by the name MDE but this code has now been exclusively assigned to the N-ethyl homologue of MDMA. It is inactive at an oral dosage of 100mg. The corresponding dimethoxy compound (3,4-dimethoxyphenyl-ẞ-ethanolamine, DME) has been studied at doses of up to 115mg and is without psychoactivity.
Beta-hydroxy-3,4-methylenedioxyphenylethyl amine is said to be a very fine trip.
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.